Viewing Study NCT03258359


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-01-04 @ 3:45 AM
Study NCT ID: NCT03258359
Status: UNKNOWN
Last Update Posted: 2020-03-04
First Post: 2017-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)
Sponsor: PersImmune, Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PACTN-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View